Nanotechnology for COVID-19: therapeutics and vaccine research

G Chauhan, MJ Madou, S Kalra, V Chopra, D Ghosh… - ACS …, 2020 - ACS Publications
The current global health threat by the novel coronavirus disease 2019 (COVID-19) requires
an urgent deployment of advanced therapeutic options available. The role of …

[HTML][HTML] Advanced implications of nanotechnology in disease control and environmental perspectives

P Biswas, SA Polash, D Dey, MA Kaium… - Biomedicine & …, 2023 - Elsevier
Nanotechnology encompasses a wide range of devices derived from biology, engineering,
chemistry, and physics, and this scientific field is composed of great collaboration among …

PLGA-based nanoparticles: an overview of biomedical applications

F Danhier, E Ansorena, JM Silva, R Coco… - Journal of controlled …, 2012 - Elsevier
Poly (lactic-co-glycolic acid)(PLGA) is one of the most successfully developed
biodegradable polymers. Among the different polymers developed to formulate polymeric …

Applications of nanotechnology for immunology

DM Smith, JK Simon, JR Baker Jr - Nature Reviews Immunology, 2013 - nature.com
Nanotechnology uses the unique properties of objects that function as a unit within the
overall size range of 1–1,000 nanometres. The engineering of nanostructure materials …

Biomedical applications of biodegradable polymers

BD Ulery, LS Nair, CT Laurencin - Journal of polymer science …, 2011 - Wiley Online Library
Utilization of polymers as biomaterials has greatly impacted the advancement of modern
medicine. Specifically, polymeric biomaterials that are biodegradable provide the significant …

Nanovaccine: An emerging strategy

A Das, N Ali - Expert review of vaccines, 2021 - Taylor & Francis
Introduction Vaccination is so far the most effective way of eradicating infections. Rapidly
emerging drug resistance against infectious diseases and chemotherapy-related toxicities in …

PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity

AL Silva, PC Soema, B Slütter… - Human vaccines & …, 2016 - Taylor & Francis
Among the emerging subunit vaccines are recombinant protein-and synthetic peptide-based
vaccine formulations. However, proteins and peptides have a low intrinsic immunogenicity …

Chitosan-based drug nanocarriers: where do we stand?

M Garcia-Fuentes, MJ Alonso - Journal of Controlled Release, 2012 - Elsevier
Chitosan-based nanocarriers have become one of the most intensively studied
transmucosal nanometric drug delivery platforms. This is due to a number of factors …

Peptide/protein vaccine delivery system based on PLGA particles

M Allahyari, E Mohit - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
abstract Due to the excellent safety profile of poly (D, L-lactide-co-glycolide)(PLGA) particles
in human, and their biodegradability, many studies have focused on the application of PLGA …

Nasal drug delivery—Recent developments and future prospects

L Illum - Journal of controlled release, 2012 - Elsevier
The present review sets out to discuss recent developments and prospects of absorption
promoters and absorption modulator systems being developed commercially by companies …